Holen Sie sich die Stockscreener-App
3.53
3.22%
0.11
Schlusskurs vom Vortag:
$3.42
Offen:
$3.5
24-Stunden-Volumen:
29,929
Relative Volume:
0.49
Marktkapitalisierung:
$29.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.81M
KGV:
-1.2232
EPS:
-2.8859
Netto-Cashflow:
$-17.01M
1W Leistung:
-1.67%
1M Leistung:
-19.59%
6M Leistung:
-58.52%
1J Leistung:
-52.93%
1-Tages-Spanne:
$3.41
$3.66
1-Wochen-Bereich:
$3.31
$3.8799
52-Wochen-Spanne:
$1.98
$13.48
Cel-Sci Corp. Stock (CVM) Company Profile
Firmenname
Cel-Sci Corp.
Sektor
Branche
Telefon
703-506-9460
Adresse
8229 Boone Boulevard, Suite 802, Vienna, VA
Compare CVM vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVM
Cel-Sci Corp.
|
3.53 | 29.86M | 0 | -23.81M | -17.01M | -2.8859 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Cel-Sci Corp. Stock (CVM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-01-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-03-02 | Eingeleitet | Dawson James | Buy |
Cel-Sci Corp. Aktie (CVM) Neueste Nachrichten
Trading Action: Is CEL SCI Corporation a strong candidate for buy and hold2026 Snapshot & Entry Point Confirmation Signals - baoquankhu1.vn
Why did CVM shares rally over 7% today? - MSN
CVM PE Ratio & Valuation, Is CVM Overvalued - Intellectia AI
CEL-SCI's Multikine Therapy Nears Critical Regulatory Milestones () - aktiencheck.de
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Volume Recap: Is Regencell Bioscience Holdings Limited stock a smart retirement pickJuly 2025 Macro Moves & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Why DID CVM Shares Rally Over 7% Today? - Stocktwits
Cel-Sci (CVM) Reports Narrower Q1 Net Loss - GuruFocus
CEL-SCI Reports Fiscal First Quarter 2026 Results - Investing News Network
Cancer therapy lifted 5-year survival to 73% in trial; next test in 2026 - Stock Titan
Cel-Sci: Fiscal Q1 Earnings Snapshot - kens5.com
Cel-Sci: Overview of First Fiscal Quarter Financial Results - Bitget
CEL SCI CORP SEC 10-Q Report - TradingView
Big Money Moves: Does CEL SCI Corporation stock have upside surprise potential - baoquankhu1.vn
Investment Review: Is CEL SCI Corporation trading at a discountJuly 2025 Snapshot & Comprehensive Market Scan Reports - baoquankhu1.vn
IPO Launch: Is CEL SCI Corporation trading at a discountWeekly Trading Summary & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Cel-Sci (NYSEAMERICAN:CVM) Stock Price Down 6.9% – Should You Sell? - Defense World
Kersten Geert buys Cel Sci (CVM) shares worth $200000 By Investing.com - Investing.com Australia
Insider Buying: Geert Kersten Acquires Additional Shares of CEL-SCI Corp (CVM) - GuruFocus
Kersten Geert buys Cel Sci (CVM) shares worth $200000 - Investing.com
Profit Recap: Does CEL SCI Corporation stock have upside surprise potentialWeekly Investment Report & Stepwise Trade Signal Implementation - baoquankhu1.vn
Cel Sci (CVM) Options Delisting Set for January 20th - GuruFocus
Surprises Report: Why CEL SCI Corporation stock could outperform in 2025M&A Rumor & AI Enhanced Trading Alerts - Bộ Nội Vụ
Cel-Sci (NYSEAMERICAN:CVM) Stock Price Down 6.5% – What’s Next? - Defense World
Cel-Sci Corporation (CVM) Investor Outlook: Exploring A Potential 625% Upside - DirectorsTalk Interviews
Is CEL SCI Corporation stock dividend yield sustainable2025 Geopolitical Influence & Long-Term Safe Investment Ideas - Улправда
Is CEL SCI Corporation stock positioned well for digital economyJuly 2025 Selloffs & Expert Curated Trade Setup Alerts - Улправда
Is CEL SCI Corporation stock a contrarian buyPortfolio Performance Summary & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
Cel-sci-sci Corp : Dutton Associates Announces Investment Opinion - marketscreener.com
CEL-SCI (CVM) Chief Scientific Officer reports purchase of 456 shares - Stock Titan
CEL-SCI (CVM) CFO Patricia Prichep reports insider stock purchase - Stock Titan
CEL-SCI Corp (CVM) CEO and Director reports purchase of 998 shares - Stock Titan
Cel-Sci Corporation (CVM) Stock Analysis: Exploring a Potential 707% Upside with Innovative Cancer Therapies - DirectorsTalk Interviews
Cel-Sci (CVM) Reduces R&D Costs and Narrows Net Loss in FY 2025 - GuruFocus
Cancer drug Multikine nears final U.S. trial, seeks Saudi breakthrough status - Stock Titan
CEL SCI CORP SEC 10-K Report - TradingView — Track All Markets
CEL-SCI (NYSE American: CVM) details Multikine survival data and cash outlook - Stock Titan
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Why CEL SCI Corporation stock is rated strong buyWeekly Risk Report & Safe Swing Trade Setups - Улправда
CEL SCI Corp CEO Acquires 8,389 Shares - TradingView — Track All Markets
CEL-SCI Corp (CVM) CEO Geert Kersten reports insider purchase of 8,389 shares - Stock Titan
Can Cel Sci Corporation stock deliver double digit returns2025 Earnings Impact & Safe Capital Allocation Plans - Newser
Will CEL SCI Corporation (LSR) stock gain from lower interest ratesJuly 2025 Analyst Calls & Free Daily Entry Point Trade Alerts - Newser
Will CEL SCI Corporation (LSR) stock attract long term capital inflowsJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - Newser
Is CEL SCI Corporation (LSR) stock resilient in recession scenarios2025 Top Decliners & Community Verified Trade Alerts - Newser
Why CEL SCI Corporation (LSR) stock is upgraded to buy2025 Short Interest & Daily Volume Surge Trade Alerts - Newser
How reliable is Cel Sci Corporation stock dividend growthJuly 2025 Movers & Smart Swing Trading Techniques - Newser
Why Cel Sci Corporation stock is upgraded to buyJuly 2025 Intraday Action & AI Enhanced Execution Alerts - Newser
Finanzdaten der Cel-Sci Corp.-Aktie (CVM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):